rs2076311

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_080680.3(COL11A2):​c.1917+70G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.311 in 1,595,442 control chromosomes in the GnomAD database, including 79,181 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.32 ( 7753 hom., cov: 32)
Exomes 𝑓: 0.31 ( 71428 hom. )

Consequence

COL11A2
NM_080680.3 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.02

Publications

29 publications found
Variant links:
Genes affected
COL11A2 (HGNC:2187): (collagen type XI alpha 2 chain) This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. It is located on chromosome 6 very close to but separate from the gene for retinoid X receptor beta. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Proteolytic processing of this type XI chain produces PARP, a proline/arginine-rich protein that is an amino terminal domain. Mutations in this gene are associated with type III Stickler syndrome, otospondylomegaepiphyseal dysplasia (OSMED syndrome), Weissenbacher-Zweymuller syndrome, autosomal dominant non-syndromic sensorineural type 13 deafness (DFNA13), and autosomal recessive non-syndromic sensorineural type 53 deafness (DFNB53). Alternative splicing results in multiple transcript variants. A related pseudogene is located nearby on chromosome 6. [provided by RefSeq, Jul 2009]
COL11A2 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 13
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
  • nonsyndromic genetic hearing loss
    Inheritance: AD, AR Classification: DEFINITIVE, MODERATE Submitted by: ClinGen
  • otospondylomegaepiphyseal dysplasia, autosomal dominant
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, Ambry Genetics, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • autosomal recessive nonsyndromic hearing loss 53
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • otospondylomegaepiphyseal dysplasia
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • otospondylomegaepiphyseal dysplasia, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • fibrochondrogenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 6-33177592-C-A is Benign according to our data. Variant chr6-33177592-C-A is described in ClinVar as Benign. ClinVar VariationId is 674972.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.368 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL11A2NM_080680.3 linkc.1917+70G>T intron_variant Intron 22 of 65 ENST00000341947.7 NP_542411.2 P13942A0A0C4DFS1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL11A2ENST00000341947.7 linkc.1917+70G>T intron_variant Intron 22 of 65 5 NM_080680.3 ENSP00000339915.2 A0A0C4DFS1
COL11A2ENST00000374708.8 linkc.1659+70G>T intron_variant Intron 20 of 63 5 ENSP00000363840.4 Q4VXY6
COL11A2ENST00000361917.6 linkc.489+70G>T intron_variant Intron 9 of 23 5 ENSP00000355123.2 H0YIS1
COL11A2ENST00000477772.1 linkn.136+70G>T intron_variant Intron 2 of 8 2

Frequencies

GnomAD3 genomes
AF:
0.315
AC:
47900
AN:
151842
Hom.:
7750
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.361
Gnomad AMI
AF:
0.409
Gnomad AMR
AF:
0.269
Gnomad ASJ
AF:
0.379
Gnomad EAS
AF:
0.225
Gnomad SAS
AF:
0.383
Gnomad FIN
AF:
0.204
Gnomad MID
AF:
0.364
Gnomad NFE
AF:
0.313
Gnomad OTH
AF:
0.325
GnomAD4 exome
AF:
0.311
AC:
448969
AN:
1443482
Hom.:
71428
Cov.:
29
AF XY:
0.314
AC XY:
225792
AN XY:
718452
show subpopulations
African (AFR)
AF:
0.387
AC:
12834
AN:
33142
American (AMR)
AF:
0.208
AC:
9210
AN:
44272
Ashkenazi Jewish (ASJ)
AF:
0.374
AC:
9706
AN:
25950
East Asian (EAS)
AF:
0.231
AC:
9106
AN:
39476
South Asian (SAS)
AF:
0.387
AC:
33184
AN:
85768
European-Finnish (FIN)
AF:
0.220
AC:
11427
AN:
52014
Middle Eastern (MID)
AF:
0.374
AC:
2147
AN:
5734
European-Non Finnish (NFE)
AF:
0.312
AC:
342716
AN:
1097350
Other (OTH)
AF:
0.312
AC:
18639
AN:
59776
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
17106
34212
51317
68423
85529
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11238
22476
33714
44952
56190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.315
AC:
47918
AN:
151960
Hom.:
7753
Cov.:
32
AF XY:
0.310
AC XY:
23008
AN XY:
74276
show subpopulations
African (AFR)
AF:
0.361
AC:
14945
AN:
41416
American (AMR)
AF:
0.268
AC:
4104
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.379
AC:
1315
AN:
3472
East Asian (EAS)
AF:
0.224
AC:
1151
AN:
5142
South Asian (SAS)
AF:
0.382
AC:
1841
AN:
4814
European-Finnish (FIN)
AF:
0.204
AC:
2163
AN:
10578
Middle Eastern (MID)
AF:
0.367
AC:
108
AN:
294
European-Non Finnish (NFE)
AF:
0.313
AC:
21241
AN:
67944
Other (OTH)
AF:
0.323
AC:
678
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1672
3344
5015
6687
8359
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
478
956
1434
1912
2390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.314
Hom.:
28408
Bravo
AF:
0.318
Asia WGS
AF:
0.327
AC:
1140
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 13, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.18
DANN
Benign
0.58
PhyloP100
-1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2076311; hg19: chr6-33145369; COSMIC: COSV107403521; COSMIC: COSV107403521; API